• Submit to IJMS Login Register
• MDPI
• Journals A-Z
• For Authors
• For Editors
• About
• Open Access Policy

• Abstract
• Full-Text PDF [785 KB]
• Full-Text XML
• Article Versions Notes
• Supplement File 1

• Article Statistics
• PubMed/Medline
• Google Scholar
• Order Reprints

• Cite this article
• Export to BibTeX
• Export to EndNote

• [+] on DOAJ
• Tseng, C
• Huang, H
• Shih, A
• Chang, Y
• Hsu, C
• Chang, J
• Li, W
• Juan, H
• [+] on Google Scholar
• Tseng, C
• Huang, H
• Shih, A
• Chang, Y
• Hsu, C
• Chang, J
• Li, W
• Juan, H
• [+] on PubMed
• Tseng, C
• Huang, H
• Shih, A
• Chang, Y
• Hsu, C
• Chang, J
• Li, W
• Juan, H

•  CiteULike
•  Facebook
•  Mendeley
•  Twitter

This article is

• freely available
• re-usable

Int. J. Mol. Sci. 2012, 13(5), 6352-6369; doi:10.3390/ijms13056352

Article

Revealing the Anti-Tumor Effect of Artificial miRNA p-27-5p on Human Breast Carcinoma Cell Line T-47D

Chien-Wei Tseng ¹ , Hsuan-Cheng Huang ² , Arthur Chun-Chieh Shih ³ , Ya-Ya Chang ¹ , Chung-Cheng Hsu ¹ , Jen-Yun Chang ¹ , Wen-Hsiung Li ^4,5,*  and Hsueh-Fen Juan ^1,*

¹ Department of Life Science, Institute of Molecular and Cellular Biology, National Taiwan University, Taipei 106, Taiwan ² Institute of Biomedical Informatics, Center for Systems and Synthetic Biology, National Yang-Ming University, Taipei 112, Taiwan ³ Institute of Information Science, Research Center for Information Technology Innovation, Academia Sinica, Taipei 115, Taiwan ⁴ Biodiversity Research Center and Genomics Research Center, Academia Sinica, Taipei 115, Taiwan ⁵ Department of Ecology and Evolution, University of Chicago, Chicago, IL 60637, USA

* Authors to whom correspondence should be addressed.

Received: 9 April 2012; in revised form: 9 May 2012 / Accepted: 18 May 2012 / Published: 23 May 2012

(This article belongs to the Special Issue Advances in Molecular Oncology)

Download PDF Full-Text [785 KB, uploaded 23 May 2012 09:35 CEST]

Abstract: microRNAs (miRNAs) cause mRNA degradation or translation suppression of their target genes. Previous studies have found direct involvement of miRNAs in cancer initiation and progression. Artificial miRNAs, designed to target single or multiple genes of interest, provide a new therapeutic strategy for cancer. This study investigates the anti-tumor effect of a novel artificial miRNA, miR P-27-5p, on breast cancer. In this study, we reveal that miR P-27-5p downregulates the differential gene expressions associated with the protein modification process and regulation of cell cycle in T-47D cells. Introduction of this novel artificial miRNA, miR P-27-5p, into breast cell lines inhibits cell proliferation and induces the first “gap” phase (G1) cell cycle arrest in cancer cell lines but does not affect normal breast cells. We further show that miR P-27-5p targets the 3′-untranslated mRNA region (3′-UTR) of cyclin-dependent kinase 4 (CDK4) and reduces both the mRNA and protein level of CDK4, which in turn, interferes with phosphorylation of the retinoblastoma protein (RB1). Overall, our data suggest that the effects of miR p-27-5p on cell proliferation and G1 cell cycle arrest are through the downregulation of CDK4 and the suppression of RB1 phosphorylation. This study opens avenues for future therapies targeting breast cancer.

Keywords: miR P-27-5p; exon array; cyclin-dependent kinase 4; cell cycle; breast cancer; retinoblastoma protein

Supplementary Files

• Supplementary File 1:

  XLS-Document (XLS, 428 KB)

Article Statistics

Cite This Article